Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China.

Wang Y, Sui Y, Qu H, Pan Y, Guan L, Qiu B, Liu L, Miao Z, Wang L, Bath PM, Johnston SC, Wang X, Chen G, Yang Q, Wu J, Ren L, Huo X, Li S, Li Z, Zhao X, Wang Y, Liao X, Wang Y, FUTURE Investigators

Open source

DOI: 10.1016/j.eclinm.2026.104115
Published: 2026 Sep
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104115,
  title = {Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China.},
  author = {Wang Y and Sui Y and Qu H and Pan Y and Guan L and Qiu B and Liu L and Miao Z and Wang L and Bath PM and Johnston SC and Wang X and Chen G and Yang Q and Wu J and Ren L and Huo X and Li S and Li Z and Zhao X and Wang Y and Liao X and Wang Y and FUTURE Investigators},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104115},
  url = {https://doi.org/10.1016/j.eclinm.2026.104115}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China.
AU  - Wang Y
AU  - Sui Y
AU  - Qu H
AU  - Pan Y
AU  - Guan L
AU  - Qiu B
AU  - Liu L
AU  - Miao Z
AU  - Wang L
AU  - Bath PM
AU  - Johnston SC
AU  - Wang X
AU  - Chen G
AU  - Yang Q
AU  - Wu J
AU  - Ren L
AU  - Huo X
AU  - Li S
AU  - Li Z
AU  - Zhao X
AU  - Wang Y
AU  - Liao X
AU  - Wang Y
AU  - FUTURE Investigators
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104115
UR  - https://doi.org/10.1016/j.eclinm.2026.104115
ER  -

APA

Y, W., Y, S., H, Q., Y, P., L, G., B, Q., L, L., Z, M., L, W., PM, B., SC, J., X, W., G, C., Q, Y., J, W., L, R., X, H., S, L., Z, L., X, Z., Y, W., X, L., Y, W., & Investigators, F. (2026). Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104115

Source records

pubmed · retrieved 2026-09-26T14:11:32.209Z